, 2003) and intimately connected with the synthesis of several virulence determinants of bacterial and other pathogens (Sritharan, 2006). To scavenge
iron from the environment, many microorganisms express high-affinity Selleck JQ1 iron acquisition systems such as deferoxamine (DFO) produced by Streptomyces pilosus (Rhodes et al., 2007). DFO, a Food and Drug Administration (FDA)-approved iron chelator, has been extensively used for chelation therapy in iron-overloaded states (Halliday & Bassett, 1980; Moreau-Marquis et al., 2009) and known to protect human red blood cells from hemin-induced hemolysis by formation of DFO-hemin complex via the iron moiety (Sullivan et al., 1992). It is also known that DFO, on the one hand, decreases the susceptibility to infections by
lowering the iron concentration, but, on the other hand, increases the virulence of some microorganisms due to Alectinib manufacturer the ability of the microorganisms to use the chelator as an iron sequestering agent for their own metabolism (van Asbeck et al., 1983b). Porphyromonas gingivalis, a major periodontal pathogen, acquires iron preferentially in the form of hemoprotein-derived hemin and stores hemin on the cell surface in μ-oxo dimeric form (μ-oxo bisheme, [Fe(III)PPIX2]O) (Lewis et al., 1999). The pathogenicity of the bacterium is markedly affected by hemin (McKee et al., 1986); P. gingivalis cells grown under hemin excess caused 100% mortality in mice, while mortality of the cells grown without Hydroxychloroquine ic50 or limited amount of hemin was less marked. Some investigations have presented that DFO mediates enhancement of polymorphonuclear leukocytes (PMN) function (van Asbeck
et al., 1984) and reduces tissue injury as well as lethality in LPS-treated mice (Vulcano et al., 2000). Moreover, local infusion of DFO, not systemically administered, has demonstrated the effectiveness in tissue protection and anti-inflammation (Lauzon et al., 2006; Hanson et al., 2009). These allow the possibility of using DFO in the periodontal disease field. Before clinical application of DFO for periodontal therapy, the effect of DFO on periodontopathogens must be evaluated. Here, we present that DFO can affect the growth and virulence of P. gingivalis through interference with the hemin utilization in the bacterium. DFO (Novartis Pharma Stein AG, Stein, Switzerland) and ferric citrate (Sigma Chemical Co., St. Louis, MO) were dissolved in distilled water and filter-sterilized. Ampicillin, tetracycline and metronidazole (Sigma) were dissolved in distilled water or methanol. Stock solutions of hemin (Sigma) were prepared in 0.02 N NaOH the same day that they were used. Carbonyl cyanide m-chlorophenylhydrazone (CCCP, Sigma) was dissolved in 20% dimethyl sulfoxide and used as inhibitor of energy-driven transport activities (Avetisyan et al., 1989). The twofold serial dilutions of DFO (0–0.
Related posts:
- The importance of the Hb binding detected in IsdA is not recogniz
- Additionally, we demon strate that P gingivalis includes a direc
- Lopinavir 192725-17-0 dysfunction of the mitochondria are connected
- , 2003), or downregulation of GABA, GAD, or pre- and postsynaptic
- This work connected information-theoretical notions to their neur